Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Anthropic’s Claude tools to compete or contribute to the healthcare sector, like OpenAI’s ChatGPT Health!
14 January 2026

Anthropic’s Claude tools to compete or contribute to the healthcare sector, like OpenAI’s ChatGPT Health!

Introduction A well-recognised AI research company, Anthropic, was founded by former OpenAI engineers who are keen to offer reliable, safe, and seamless artificial general intelligence for smart individuals and the future of the new tech world. The company is popular for its well-structured AI ecos...

Nona’s expanding initiatives to fuel modality solutions, tech platform and more
13 January 2026

Nona’s expanding initiatives to fuel modality solutions, tech platform and more

Introduction Nona Biosciences, a biotech entity along with its robust exclusive Harbour Mice® platform, is producing full-fledged human antibodies and has dug into AI-powered tools such as Hu-mAtrIx™. The company discover this AI tools in collaboration with pharma and academia to prepare ...

BioVaxys’s study results are out, featuring improvement of DPX™
13 January 2026

BioVaxys’s study results are out, featuring improvement of DPX™

Introduction BioVaxys Technology Corp. is a clinically devoted biotechnology company that promises to introduce novel immunotherapies involving antiviral vaccines and cancer. The company’s exclusive DPX™ and HapTenix® comprehensive technology platforms heal extreme allergies, autoim...

Lilly tightens its deals and accelerates its share buyout to bolster its Inflammatory Pipeline
13 January 2026

Lilly tightens its deals and accelerates its share buyout to bolster its Inflammatory Pipeline

Introduction Eli Lilly is a person who named its pharmaceutical firm with the same name and shone for its high-quality medicines. Since 1876, Eli’s long-term vision and urge to introduce science-based healing brought the company close to success. Today, it's working on oncology, immunology an...

Parabilis Medicines’ million-dollar help to upgrade the Cancer Drug space
13 January 2026

Parabilis Medicines’ million-dollar help to upgrade the Cancer Drug space

Introduction Parabilis Medicines, formerly FogPharma, is a well-established clinical-level biopharma company passionate about developing effective peptide therapeutics known as Helicons. Helicon is like a weapon to protect undruggable cancer targets and fight all odds that disrupt focus. Parabilis ...

Protara completes first patient dosing, taking one step ahead in its THRIVE-3 Trial
12 January 2026

Protara completes first patient dosing, taking one step ahead in its THRIVE-3 Trial

Introduction Protara Therapeutics, Inc. is a leading clinical-level biopharmaceutical company that has worked wonders in establishing life-changing, effective therapies for rare diseases and cancer. The company also conducted some major programs that brought awareness and development in certain cru...

ABS’s buyout of Cureline’s excellence to bolster biopharma drug discovery
12 January 2026

ABS’s buyout of Cureline’s excellence to bolster biopharma drug discovery

Introduction ABS Bio, since its establishment in 1990, has delivered the best-in-class critical scientific relevant services involving tissue processing, cell culture, human biospecimens, biostorage and cell line engineering. This contributed a lot to biotech and pharmaceutical companies building a...

Jazz shows progress in stomach cancer with its promising findings
12 January 2026

Jazz shows progress in stomach cancer with its promising findings

Introduction Jazz Pharmaceuticals, an Ireland-based company famous for its ‘Ziihera’ (zanidatamab), which is a prescription-based medicine have been serving a total of 75 countries with its comprehensive products. With the robust pipeline and products travelling across countries and ear...

Crinetics bets a million relying on its new Phase 2 results
12 January 2026

Crinetics bets a million relying on its new Phase 2 results

Introduction Crinetics Pharmaceuticals is popular for discovering new medicines for curing endocrine-based diseases. The company came into force in 2008 with its regional origin in San Diego, California. The founders of the company, Frank Zhu, Scott Struthers, Stephen F. Betz and Ana Kusnetzow, sta...

Novoron secured funding from NIH/NIA SBIR for its Alzheimer’s Drug Discovery
09 January 2026

Novoron secured funding from NIH/NIA SBIR for its Alzheimer’s Drug Discovery

Announcement Novoron Bioscience, a well-known biotechnology company in San Diego since 2014, has been establishing new therapies for neurological injury and neurodegenerative diseases, and has now earned worth $2.5 million reward from the National Institute on Aging at the National Institutes of He...

WhatsApp